MedTrace Logo

Efficacy of InteguSeal for Surgical Skin Preparation in Patients Undergoing Total Joint Replacement

NCT00829556 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2009-12-21

No results posted yet for this study

Summary

This study is being conducted to investigate the potential benefits of using a special type of fluid that can be applied to the skin (Integuseal) in addition to standard surgical skin preparation in patients undergoing total hip replacement (THA) or total knee replacement (TKA). Integuseal is supposed to lock down the skin bacteria and reduce skin infection and other problems. This study will investigate whether Integuseal is effective in reducing persistent wound drainage when used in addition to standard surgical skin preparation for total hip arthroplasty (THA) or total knee replacement (TKA).

Conditions

  • Prosthetic Joint Infection
  • Surgical Skin Infection

Interventions

DEVICE

Integuseal

Sponsors & Collaborators

  • Kimberly-Clark Corporation

    collaborator INDUSTRY

  • Rothman Institute Orthopaedics

    lead OTHER

Principal Investigators

  • Javad Parvizi, MD, FRCS · Rothman Institute Orthopaedics

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2009-08-31
Completion
2009-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00829556 on ClinicalTrials.gov